Research Article
Year 2021,
, 241 - 248, 30.09.2021
Abstract
References
- 1) Dhama K, Sharun K, Tiwari R, Dadar M, Malik YS, Singh KP, Chaicumpa W. COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics. Hum Vaccin Immunother. 2020; 16(6):1232 1238.
- 2) Kazan Kizilkurt O, Dilbaz N, Noyan CO. Psychological Impact of COVID-19 Pandemic on General Population in Turkey: Risk Factors. Asia Pac J Public Health. 2020 ;32(8):519
- 3) American College of Obstetricians and Gynecologists' Committee on Practice Bulletins—Gynecology. Female Sexual Dysfunction: ACOG Practice Bulletin Clinical Management Guidelines for Obstetrician-Gynecologists, Number 213. Obstet Gynecol. 2019;134(1): e1-e18.
- 4) Reddy RM, Saravanan RA, Praharaj SK, Thirunavukarasu M. Sexual Dysfunction in Women with Depression: A Hospital-Based Cross-sectional Comparative Study. Indian J Psychol Med. 2020 6;42(1):46-51.
- 5) Shifren JL, Monz BU, Russo PA, Segreti A, Johannes CB. Sexual problems and distress in United States women: prevalence and correlates. Obstet Gynecol 2008; 112:970–8. (Level II-3)
- 6) Oksuz E, Malhan S. Prevalence and risk factors for female sexual dysfunction in Turkish women. J Urol. 2006;175(2):654-8; discussion 658.
- 7) Cayan S, Akbay E, Bozlu M, Canpolat B, Acar D, Ulusoy E. The prevalence of female sexual dysfunction and potential risk factors that may impair sexual function in Turkish women. Urol Int. 2004;72(1):52-7.
- 8) Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, Ferguson D, D'Agostino R Jr. The Female Sexual Function Index (FSFI): A multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther.2000; 26: 191-208.
- 9) Oksuz E, Malhan S: Kadın cinsel fonksiyon indeksi: Türkçe uyarlamasının geçerlilik ve güvenilirlik analizi Sendrom,2005;17: 54-60.
- 10) Wiegel M, Meston C, Rosen R: The female sexual function index (FSFI): cross-validation and development of clinical cutoff scores. J Sex Marital Ther. 2005;31: 1-20.
- 11) Enstitüsü, Hacettepe Üniversitesi Nüfus Etütleri. "Türkiye Nüfus ve Sağlık Araştırması (2018)."
- 12) Li W, Li G, Xin C, Wang Y, Yang S. Challenges in the Practice of Sexual Medicine in the Time of COVID-19 in China. J Sex Med. 2020;17(7):1225-1228
- 13) Cito G, Micelli E, Cocci A, Polloni G, Russo GI, Coccia ME, Simoncini T, Carini M, Minervini A, Natali A. The Impact of the COVID-19 Quarantine on Sexual Life in Italy. Urology. 202;147:37-42.
- 14) Karsiyakali N, Sahin Y, Ates HA, Okucu E, Karabay E. Evaluation of the Sexual Functioning of Individuals Living in Turkey During the COVID-19 Pandemic: An Internet-Based Nationwide Survey Study. Sex Med. 2020 26;9(1):100279.
- 15) Karakas LA, Azemi A, Simsek SY, Akilli H, Esin S. Risk factors for sexual dysfunction in pregnant women during the COVID-19 pandemic. Int J Gynaecol Obstet. 2021;152(2):226-230.
- 16) Bartellas E, Crane JM, Daley M, Bennett KA, Hutchens D. Sexuality and sexual activity in pregnancy. BJOG. 2000;107(8):964-8.
- 17) Ahmed MR, Madny EH, Sayed Ahmed WA. Prevalence of female sexual dysfunction during pregnancy among Egyptian women. J Obstet Gynaecol Res. 2014;40(4):1023-9.
- 18) Naldoni LM, Pazmiño MA, Pezzan PA, Pereira SB, Duarte G, Ferreira CH. Evaluation of sexual function in Brazilian pregnant women. J Sex Marital Ther. 2011;37(2):116-29.
- 19) Küçükdurmaz F, Efe E, Malkoç Ö, Kolus E, Amasyalı AS, Resim S. Prevalence and correlates of female sexual dysfunction among Turkish pregnant women. Turk J Urol. 2016;42(3):178-83.
- 20) Aydin M, Cayonu N, Kadihasanoglu M, Irkilata L, Atilla MK, Kendirci M. Comparison of Sexual Functions in Pregnant and Non-Pregnant Women. Urol J. 2015 14;12(5):2339-44.
- 21) Yang YQ, Xu Q, Tong WJ, Gao CL, Li HM. Sexual Dysfunction among Chinese Nurses: Prevalence and Predictors. Biomed Environ Sci. 2017;30(3):229-234.
- 22) Stamatiou K, Margariti M, Nousi E, Mistrioti D, Lacroix R, Saridi M. Female Sexual Dysfunction (Fsd) In Women Health Care Workers. Mater Sociomed. 2016;28(3):178-82.
- 23) Safdar F, Eng CLJ, Wai KL, Tey WS, Ang SB. Prevalence of female sexual dysfunction in allied health workers: a cross-sectional pilot study in a tertiary hospital in Singapore. BMC Womens Health. 2019; 14;19(1):137.
- 24) Astepe BS, Köleli I. A cross-sectional study of female sexual dysfunction among Turkish pregnant and nonpregnant women: correlation with hormone profile. The European Research Journal. 2018.
- 25) Aggarwal RS, Mishra VV, Panchal NA, Patel NH, Deshchougule VV, Jasani AF. Sexual dysfunction in women: an overview of risk factors and prevalence in Indian women. JSAFOG. 2012;4(3):134–6.
- 26) Jaafarpour M, Khani A, Khajavikhan J, Suhrabi Z. Female sexual dysfunction: prevalence and risk factors. J Clin Diagn Res. 2013;7(12):2877–80.
- 27) McCool-Myers M, Theurich M, Zuelke A, Knuettel H, Apfelbacher C. Predictors of female sexual dysfunction: a systematic review and qualitative analysis through gender inequality paradigms. BMC Womens Health. 2018; 22;18(1):108.
- 28) Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA. 1999 Feb 10;281(6):537-44. doi: 10.1001/jama.281.6.537. Erratum in: JAMA 1999 7;281(13):1174.
- 29) Saotome TT, Yonezawa K, Suganuma N. Sexual Dysfunction and Satisfaction in Japanese Couples During Pregnancy and Postpartum. Sex Med. 2018;6(4):348-355.
- 30) Ghorat F, Esfehani RJ, Sharifzadeh M, Tabarraei Y, Aghahosseini SS. Long term effect of vaginal delivery and cesarean section on female sexual function in primipara mothers. Electron Physician. 2017 25;9(3):3991-3996.
- 31) Kahramanoglu I, Baktiroglu M, Hamzaoglu K, Kahramanoglu O, Verit FF, Yucel O. The impact of mode of delivery on the sexual function of primiparous women: a prospective study. Arch Gynecol Obstet. 2017;295(4):907-916.
Sexual dysfunction in women during COVID-19 pandemic: A hospital-based, prospective, cross-sectional comparative study
Abstract
Objective: International studies have shown that overall sexual activity and frequency of sexual intercourse decreased significantly during the COVID-19 pandemic. The aim of this study is to compare the female sexual dysfunction (FSD) rate in women during the COVID-19 pandemic in tertiary hospital in Turkey.
Method: A total of 150 participants who were 50 pregnant women (group I), 50 healthcare women (group II) and 50 other women (group III), participated in study. A female sexual function index (FSFI) questionnaire was applied to the women along with the questions of age, education level, delivery methods, smoking, employment status and socioeconomic levels. The sexual dysfunction rate and female sexual function index scores between the groups were compared.
Results: The median FSFI score was 23.50 in the present study population. Median scores were 22.1, 26.5, and 23.1 for groups I (pregnant), II (healthcare workers) and III (others), respectively. When the FSFI scores of the groups were compared, the FSFI score of group II was statistically significantly higher than the other groups (p: 0,001). By using the cutoff FSFI score of 26.55, 68.7 % (n:103) of women were diagnosed as having sexual dysfunction. The rates of sexual dysfunction as follows 84%, 52%, and 70% for groups I, II and III, respectively. When analyzed with FSFI domains one by one, it was seen that Group 2 had a statistically significantly higher FSFI score in the areas of Arousal, Lubrication, Orgasm, and Pain compared to the other groups.
Conclusions: The prevalence of FSD in Turkey increased during COVID-19 pandemic. When comparing female sexual dysfunction prevalence in groups, the lowest sexual dysfunction prevalence was found in healthcare workers. Prevalence of sexual dysfunction was found to be associated with women's employment and educational status.
References
- 1) Dhama K, Sharun K, Tiwari R, Dadar M, Malik YS, Singh KP, Chaicumpa W. COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics. Hum Vaccin Immunother. 2020; 16(6):1232 1238.
- 2) Kazan Kizilkurt O, Dilbaz N, Noyan CO. Psychological Impact of COVID-19 Pandemic on General Population in Turkey: Risk Factors. Asia Pac J Public Health. 2020 ;32(8):519
- 3) American College of Obstetricians and Gynecologists' Committee on Practice Bulletins—Gynecology. Female Sexual Dysfunction: ACOG Practice Bulletin Clinical Management Guidelines for Obstetrician-Gynecologists, Number 213. Obstet Gynecol. 2019;134(1): e1-e18.
- 4) Reddy RM, Saravanan RA, Praharaj SK, Thirunavukarasu M. Sexual Dysfunction in Women with Depression: A Hospital-Based Cross-sectional Comparative Study. Indian J Psychol Med. 2020 6;42(1):46-51.
- 5) Shifren JL, Monz BU, Russo PA, Segreti A, Johannes CB. Sexual problems and distress in United States women: prevalence and correlates. Obstet Gynecol 2008; 112:970–8. (Level II-3)
- 6) Oksuz E, Malhan S. Prevalence and risk factors for female sexual dysfunction in Turkish women. J Urol. 2006;175(2):654-8; discussion 658.
- 7) Cayan S, Akbay E, Bozlu M, Canpolat B, Acar D, Ulusoy E. The prevalence of female sexual dysfunction and potential risk factors that may impair sexual function in Turkish women. Urol Int. 2004;72(1):52-7.
- 8) Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, Ferguson D, D'Agostino R Jr. The Female Sexual Function Index (FSFI): A multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther.2000; 26: 191-208.
- 9) Oksuz E, Malhan S: Kadın cinsel fonksiyon indeksi: Türkçe uyarlamasının geçerlilik ve güvenilirlik analizi Sendrom,2005;17: 54-60.
- 10) Wiegel M, Meston C, Rosen R: The female sexual function index (FSFI): cross-validation and development of clinical cutoff scores. J Sex Marital Ther. 2005;31: 1-20.
- 11) Enstitüsü, Hacettepe Üniversitesi Nüfus Etütleri. "Türkiye Nüfus ve Sağlık Araştırması (2018)."
- 12) Li W, Li G, Xin C, Wang Y, Yang S. Challenges in the Practice of Sexual Medicine in the Time of COVID-19 in China. J Sex Med. 2020;17(7):1225-1228
- 13) Cito G, Micelli E, Cocci A, Polloni G, Russo GI, Coccia ME, Simoncini T, Carini M, Minervini A, Natali A. The Impact of the COVID-19 Quarantine on Sexual Life in Italy. Urology. 202;147:37-42.
- 14) Karsiyakali N, Sahin Y, Ates HA, Okucu E, Karabay E. Evaluation of the Sexual Functioning of Individuals Living in Turkey During the COVID-19 Pandemic: An Internet-Based Nationwide Survey Study. Sex Med. 2020 26;9(1):100279.
- 15) Karakas LA, Azemi A, Simsek SY, Akilli H, Esin S. Risk factors for sexual dysfunction in pregnant women during the COVID-19 pandemic. Int J Gynaecol Obstet. 2021;152(2):226-230.
- 16) Bartellas E, Crane JM, Daley M, Bennett KA, Hutchens D. Sexuality and sexual activity in pregnancy. BJOG. 2000;107(8):964-8.
- 17) Ahmed MR, Madny EH, Sayed Ahmed WA. Prevalence of female sexual dysfunction during pregnancy among Egyptian women. J Obstet Gynaecol Res. 2014;40(4):1023-9.
- 18) Naldoni LM, Pazmiño MA, Pezzan PA, Pereira SB, Duarte G, Ferreira CH. Evaluation of sexual function in Brazilian pregnant women. J Sex Marital Ther. 2011;37(2):116-29.
- 19) Küçükdurmaz F, Efe E, Malkoç Ö, Kolus E, Amasyalı AS, Resim S. Prevalence and correlates of female sexual dysfunction among Turkish pregnant women. Turk J Urol. 2016;42(3):178-83.
- 20) Aydin M, Cayonu N, Kadihasanoglu M, Irkilata L, Atilla MK, Kendirci M. Comparison of Sexual Functions in Pregnant and Non-Pregnant Women. Urol J. 2015 14;12(5):2339-44.
- 21) Yang YQ, Xu Q, Tong WJ, Gao CL, Li HM. Sexual Dysfunction among Chinese Nurses: Prevalence and Predictors. Biomed Environ Sci. 2017;30(3):229-234.
- 22) Stamatiou K, Margariti M, Nousi E, Mistrioti D, Lacroix R, Saridi M. Female Sexual Dysfunction (Fsd) In Women Health Care Workers. Mater Sociomed. 2016;28(3):178-82.
- 23) Safdar F, Eng CLJ, Wai KL, Tey WS, Ang SB. Prevalence of female sexual dysfunction in allied health workers: a cross-sectional pilot study in a tertiary hospital in Singapore. BMC Womens Health. 2019; 14;19(1):137.
- 24) Astepe BS, Köleli I. A cross-sectional study of female sexual dysfunction among Turkish pregnant and nonpregnant women: correlation with hormone profile. The European Research Journal. 2018.
- 25) Aggarwal RS, Mishra VV, Panchal NA, Patel NH, Deshchougule VV, Jasani AF. Sexual dysfunction in women: an overview of risk factors and prevalence in Indian women. JSAFOG. 2012;4(3):134–6.
- 26) Jaafarpour M, Khani A, Khajavikhan J, Suhrabi Z. Female sexual dysfunction: prevalence and risk factors. J Clin Diagn Res. 2013;7(12):2877–80.
- 27) McCool-Myers M, Theurich M, Zuelke A, Knuettel H, Apfelbacher C. Predictors of female sexual dysfunction: a systematic review and qualitative analysis through gender inequality paradigms. BMC Womens Health. 2018; 22;18(1):108.
- 28) Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA. 1999 Feb 10;281(6):537-44. doi: 10.1001/jama.281.6.537. Erratum in: JAMA 1999 7;281(13):1174.
- 29) Saotome TT, Yonezawa K, Suganuma N. Sexual Dysfunction and Satisfaction in Japanese Couples During Pregnancy and Postpartum. Sex Med. 2018;6(4):348-355.
- 30) Ghorat F, Esfehani RJ, Sharifzadeh M, Tabarraei Y, Aghahosseini SS. Long term effect of vaginal delivery and cesarean section on female sexual function in primipara mothers. Electron Physician. 2017 25;9(3):3991-3996.
- 31) Kahramanoglu I, Baktiroglu M, Hamzaoglu K, Kahramanoglu O, Verit FF, Yucel O. The impact of mode of delivery on the sexual function of primiparous women: a prospective study. Arch Gynecol Obstet. 2017;295(4):907-916.
There are 31 citations in total.
Details
| Primary Language | English |
|---|---|
| Subjects | Health Care Administration |
| Journal Section | Surgical Science Research Articles |
| Authors | |
| Publication Date | September 30, 2021 |
| Acceptance Date | August 20, 2021 |
| Published in Issue | Year 2021 |